In a collaborative effort, AACT jointly with ACMT are active participants in the Choosing Wisely campaign. Choosing Wisely promotes conversations between clinicians and patients to allow patients to choose care that is supported by evidence; not duplicative; free from harm and truly necessary. The complete list of this joint effort is available here.
In a collaborative effort, AACT has engaged with multiple professional societies to establish a multidisciplinary workgroup to evaluate the evidence for intravenous lipid emulsion therapy in acutely poisoned patients. Ad hoc consultants were employed in the rigorous evaluation of the literature.